New AstraZeneca facility in Tuas South to create over 800 jobs, ready by 2029

Quick Summary:

The 58-acre site at Tuas South will be the first of its kind for the company to produce cancer medicines.

It had previously announced its intention to build the US$1.5 billion (S$2 billion) facility in May, but did not indicate the location of the site and the estimated number of jobs created.

The new facility will be AstraZeneca’s first end-to-end antibody drug conjugates production site globally.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Category: EconomyBusiness

Markets: Singapore

Topics: Manufacturing Astrazeneca’s Site Singapore Jobs Industry Biopharmaceutical Facility Singapore’s First Build

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-11-07 @ 14:10:00 (4 hours ago)

News Timezone: GMT +8:00

News Source URL: straitstimes.com

Language: English

Article Length: 620 words

Reading Time: 4 minutes read

Sentences: 25 lines

Sentence Length: 25 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © The Straits Times

News ID: 23458235

View Article Analysis

About The Straits Times

Main Topics: EconomyBusiness

Official Website: straitstimes.com

Update Frequency: 19 posts per day

Year Established: 1845

Headquarters: Singapore

News Last Updated: 2 hours ago

Coverage Areas: Singapore

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Local / Regional

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #25

Publisher Details

Frequently Asked Questions